Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.

Globoid-cell Leukodystrophy (GLD; Krabbe's disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adarsh S Reddy, Jigisha R Patel, Carole Vogler, Robyn S Klein, Mark S Sands
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b6d54ba5f817454e85535cf206aefb9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b6d54ba5f817454e85535cf206aefb9f
record_format dspace
spelling oai:doaj.org-article:b6d54ba5f817454e85535cf206aefb9f2021-11-18T07:43:17ZCentral nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.1932-620310.1371/journal.pone.0064647https://doaj.org/article/b6d54ba5f817454e85535cf206aefb9f2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23755134/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Globoid-cell Leukodystrophy (GLD; Krabbe's disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphingosine (psychosine). This leads to a rapidly progressive fatal disease with spasticity, cognitive disability and seizures. The murine model of GLD (Twitcher; GALC-/-) lacks the same enzyme and has similar clinical features. The deficiency of GALC leads to oligodendrocyte death, profound neuroinflammation, and the influx of activated macrophages into the CNS. We showed previously that keratinocyte chemoattractant factor (KC) is highly elevated in the CNS of untreated Twitcher mice and significantly decreases after receiving a relatively effective therapy (bone marrow transplantation combined with gene therapy). The action of KC is mediated through the CXCR2 receptor and is a potent chemoattractant for macrophages and microglia. KC is also involved in oligodendrocyte migration and proliferation. Based on the commonalities between the disease presentation and the functions of KC, we hypothesized that KC and/or CXCR2 contribute to the pathogenesis of GLD. Interestingly, the course of the disease is not significantly altered in KC- or CXCR2-deficient Twitcher mice. There is also no alteration in inflammation or demyelination patterns in these mice. Furthermore, transplantation of CXCR2-deficient bone marrow does not alter the progression of the disease as it does in other models of demyelination. This study highlights the role of multiple redundant cytokines and growth factors in the pathogenesis of GLD.Adarsh S ReddyJigisha R PatelCarole VoglerRobyn S KleinMark S SandsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 6, p e64647 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Adarsh S Reddy
Jigisha R Patel
Carole Vogler
Robyn S Klein
Mark S Sands
Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
description Globoid-cell Leukodystrophy (GLD; Krabbe's disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphingosine (psychosine). This leads to a rapidly progressive fatal disease with spasticity, cognitive disability and seizures. The murine model of GLD (Twitcher; GALC-/-) lacks the same enzyme and has similar clinical features. The deficiency of GALC leads to oligodendrocyte death, profound neuroinflammation, and the influx of activated macrophages into the CNS. We showed previously that keratinocyte chemoattractant factor (KC) is highly elevated in the CNS of untreated Twitcher mice and significantly decreases after receiving a relatively effective therapy (bone marrow transplantation combined with gene therapy). The action of KC is mediated through the CXCR2 receptor and is a potent chemoattractant for macrophages and microglia. KC is also involved in oligodendrocyte migration and proliferation. Based on the commonalities between the disease presentation and the functions of KC, we hypothesized that KC and/or CXCR2 contribute to the pathogenesis of GLD. Interestingly, the course of the disease is not significantly altered in KC- or CXCR2-deficient Twitcher mice. There is also no alteration in inflammation or demyelination patterns in these mice. Furthermore, transplantation of CXCR2-deficient bone marrow does not alter the progression of the disease as it does in other models of demyelination. This study highlights the role of multiple redundant cytokines and growth factors in the pathogenesis of GLD.
format article
author Adarsh S Reddy
Jigisha R Patel
Carole Vogler
Robyn S Klein
Mark S Sands
author_facet Adarsh S Reddy
Jigisha R Patel
Carole Vogler
Robyn S Klein
Mark S Sands
author_sort Adarsh S Reddy
title Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
title_short Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
title_full Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
title_fullStr Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
title_full_unstemmed Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
title_sort central nervous system pathology progresses independently of kc and cxcr2 in globoid-cell leukodystrophy.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/b6d54ba5f817454e85535cf206aefb9f
work_keys_str_mv AT adarshsreddy centralnervoussystempathologyprogressesindependentlyofkcandcxcr2ingloboidcellleukodystrophy
AT jigisharpatel centralnervoussystempathologyprogressesindependentlyofkcandcxcr2ingloboidcellleukodystrophy
AT carolevogler centralnervoussystempathologyprogressesindependentlyofkcandcxcr2ingloboidcellleukodystrophy
AT robynsklein centralnervoussystempathologyprogressesindependentlyofkcandcxcr2ingloboidcellleukodystrophy
AT markssands centralnervoussystempathologyprogressesindependentlyofkcandcxcr2ingloboidcellleukodystrophy
_version_ 1718423057660379136